Clinical trials
Carcinoma, Non-Small-Cell Lung trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
634 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 3 |
| 2004 | 5 |
| 2005 | 8 |
| 2006 | 14 |
| 2007 | 13 |
| 2008 | 21 |
| 2009 | 19 |
| 2010 | 16 |
| 2011 | 18 |
| 2012 | 18 |
| 2013 | 19 |
| 2014 | 27 |
| 2015 | 36 |
| 2016 | 24 |
| 2017 | 34 |
| 2018 | 37 |
| 2019 | 47 |
| 2020 | 45 |
| 2021 | 45 |
| 2022 | 45 |
| 2023 | 38 |
| 2024 | 46 |
| 2025 | 33 |
| 2026 | 18 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 267 |
| Active, not recruiting | 126 |
| Recruiting | 93 |
| Terminated | 75 |
| Unknown status | 62 |
| Withdrawn | 3 |
| Not yet recruiting | 3 |
| Enrolling by invitation | 2 |
| No longer available | 1 |
| Available | 1 |
| Approved for marketing | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 62 |
| Hoffmann-La Roche | 41 |
| Novartis Pharmaceuticals | 37 |
| Merck Sharp & Dohme LLC | 34 |
| Eli Lilly and Company | 32 |
| Samsung Medical Center | 28 |
| Pfizer | 27 |
| Yonsei University | 20 |
| Boehringer Ingelheim | 17 |
| Bristol-Myers Squibb | 16 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 634 |
| Lung Neoplasms | 113 |
| Neoplasms | 76 |
| Neoplasm Metastasis | 52 |
| Colorectal Neoplasms | 42 |
| Breast Neoplasms | 28 |
| Squamous Cell Carcinoma of Head and Neck | 27 |
| Pancreatic Neoplasms | 26 |
| Stomach Neoplasms | 25 |
| Carcinoma | 24 |
Trials
Showing 1 to 25 of 634. Each trial links to its page on Pharma Observatory.
534 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.